A new paper from our group examines the combined presence of high blood glucose and low tyrosine metabolism in people with Major Depressive Disorder.
Several institutions and organizations including our own are advancing the research of anti-inflammatory drugs as treatment methods for depression and depressive symptoms. Read about it at Nature.
Neuroinflammation is rapidly being tied to a number of physical and cognitive health issues, presenting a new direction for potential treatments.
How can you maintain your motivation during stressful times? Our research provides one answer. See more at Inc.
Computational modeling provides a new look at chronic, low grade inflammation’s effects on motivation. Read more at Medical Express.
Inflammation research at Emory helps develop our understanding of treatment-resistant depression. Dr. Miller discusses this research with Healio.